Center for Nanomedicine Research
Introduction | Objectives | Members
Introduction
Nanomedicine is the application of nanotechnology (the engineering of tiny machines) to the prevention and treatment of disease in the human body. Nanomedicine exploration is the biologically motivated discovery and development that will incorporate nanotechnology tools, devices and processes to provide fundamental insights into cellular function and dysfunction, and leading to therapeutic interventions for disease. This discipline is still in its infancy. It has the potential to change medical science dramatically in the 21st century.
Mission
The Center for Nanomedicine Research at NHRI was officially established in 2004 to integrate the interdisciplinary research teams to explore the important medical issues provide possible resolutions to possible solutions to important medical diagnosis, prognosis and therapeutics that are still obstacles according to the current science and technology. The C-NMR/NI will also be responsible for promoting the applications of nanotechnology to medically important issues in Taiwan. The goals for C-NMR/NHRI are:
- to integrate and coordinate the intramural and interdivisional nanomedicine researches at NHRI;
- to integrate and coordinate the extramural nanomedicine research activities through collaborations with universities, medical center;
- to educate and incubate the research manpower in the nanomedicine field of Taiwan;
- to provide a platform for the exchange of research experience and activities for nanomedicine researchers.
Core Facility
- 1. Transmission Electronic Microscope,
TEM,
Model: Hitachi, H-7650 - 2. Field Emission-Scanning Electron Microscopy,
FE-SEM, SEM
Model: Hitachi, S-4700, type-I - 3. Atomic Force Microscope (Scanning probe
microscope)
Model: Vecco /DI
Achievements
- 1. Nano particle accommodation apparatus, nano particle detection system and method thereof / 95123229/ 60/826,770 (Taiwan/US Patent pending)
- 2. Implantable microdevice for detecting, activating and delivering molecules / 60/828,465 (US Patent pending)
- 3. Kit for preparation of nano-targeted liposome drug in combined radionuclide therapy and chemotherapy./ 96110033/ 11684650 (Taiwan/US Patent pending)
- 4. A biodegradable material with nanopores and electric conductivity and the fabricating method thereof / 096100482 (Taiwan/US / EU Patent pending)
- 5. Ischemia control system, tension adjustable instrument and method thereof / 60/954,423 (Taiwan/US Patent pending)
- 6. Drug release from thermosensitive liposomes by applying an alternative magnetic field / 60/946,532 (Taiwan/US Patent pending)